Emilie McNair
Family · Winston Salem, NCNPI 1932465069
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 100.0% of the total across 63 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. It is spread thinly across 26 manufacturers, the largest accounting for just 15.2% — the pattern of someone who eats at a lot of different presentations. 2025 is the largest year on record at $1,588, more than ten times the $90 reported in 2021. Among family clinicians in NC with any reported payments, this total sits in the top 10% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 63 payments — averaging $81.93 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Novo Nordisk$782
- AstraZeneca$744
- Otsuka America Pharmaceutical, Inc.$370
- Bayer$368
- Neurocrine Biosciences, Inc.$363
- Acadia Pharmaceuticals Inc$250
- plus $2K from 20 others
What the payments were for
- Food & beverage$5,161100%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Novo Nordisk | 10 | $782 |
| AstraZeneca(2 entities) | 9 | $744 |
| Otsuka America Pharmaceutical, Inc. | 3 | $370 |
| Bayer | 8 | $368 |
| Neurocrine Biosciences, Inc. | 4 | $363 |
| Acadia Pharmaceuticals Inc | 4 | $250 |
| AbbVie | 2 | $250 |
| Boehringer Ingelheim | 2 | $248 |
| Madrigal Pharmaceuticals | 2 | $238 |
| Sanofi-aventis U.S. LLC | 2 | $150 |
| Sumitomo Pharma America, Inc. | 1 | $125 |
| Xeris Pharmaceuticals, Inc. | 1 | $123 |
| Averitas Pharma Inc. | 1 | $123 |
| Genentech USA, Inc. | 1 | $122 |
| Scpharmaceuticals Inc. | 1 | $122 |
| Amarin Pharma, Inc. | 1 | $121 |
| Idorsia Pharmaceuticals US Inc | 1 | $121 |
| ARS Pharmaceuticals Operations, Inc. | 1 | $100 |
| Corcept Therapeutics | 1 | $96 |
| Evofem Biosciences, Inc. | 1 | $89 |
| Axonics, Inc. | 1 | $82 |
| Scynexis, Inc. | 1 | $56 |
| Collegium Pharmaceutical, Inc. | 2 | $39 |
| Medtronic | 1 | $34 |
| Exact Sciences | 1 | $25 |
| Organon | 1 | $21 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$5,161 in reported general payments places this provider in the 90th percentile of 4,522 family providers in North Carolina.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| TrulicityDulaglutide | 12 | $21,412 |
| FarxigaDapagliflozin Propanediol | 11 | $10,200 |
| Lantus SolostarInsulin Glargine,hum.Rec.Anlog | 14 | $899 |
| Metoprolol Succinate | 14 | $282 |
| Metformin Hcl | 21 | $221 |
| Amlodipine Besylate | 27 | $178 |
| Lisinopril | 17 | $139 |
| Losartan Potassium | 11 | $77 |
| Atorvastatin Calcium | 13 | $58 |
| Pantoprazole Sodium | 12 | $48 |
| Hydrochlorothiazide | 18 | $42 |
| Meclizine Hcl | 15 | $7 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| AstraZenecaFarxiga | $744 | $10,20011 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 90th percentile of 4,522 family providers in North Carolina.
Other family in Winston Salem
- Elena McGintyWinston Salem$28K
- Amy BilickiWinston Salem$12K
- Leslie ByrneFayetteville$482K
- Michele CerraRaleigh$332K
- Anne LakeArchdale$306K
- Carrie PettitRaleigh$298K
- Nicole RothmanDurham$268K
- Meredith LeaYanceyville$253K
- Jennifer GibbsRaleigh$216K
- Juanita PerkinsDurham$213K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.